| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |